Iron isomaltoside for anemia in peritoneal dialysis patients
Treatments studied
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial tests if an intravenous iron medication (iron isomaltoside) can improve anemia in patients on peritoneal dialysis. It may help those whose iron levels are low despite stable use of other anemia treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have been on peritoneal dialysis for at least 3 months.
- Your hemoglobin must be 110 g/L or lower at the screening visit.
- Your iron stores (ferritin or transferrin saturation) must be low.
- You must not have taken any oral or IV iron in the last 4 weeks.
- You must be on a stable dose of your current anemia medication (if using one) for the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a higher or lower dose of iron works better for people on peritoneal dialysis who have low iron levels. It aims to find the best way to treat iron deficiency in this group.
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
This trial studies whether taking iron by mouth can improve iron levels and anemia (low red blood cell counts) in children with chronic kidney disease. It may help reduce fatigue and support normal blood-making, by comparing different approaches for children who meet specific iron test results.
This trial tests whether a new blood test (reticulocyte hemoglobin) is better than the usual iron test (transferrin saturation) for guiding when to give iron to people on dialysis. If you have anemia (low red blood cells) from kidney disease, this study may help doctors find the best way to treat your iron levels.
This study tests whether giving intravenous iron improves symptoms, quality of life, and exercise ability in people with heart failure and low iron levels. Participants will receive iron infusions and be monitored over time to see if their condition improves.
This study tests whether intravenous (IV) iron therapy can help older adults who have heart failure with preserved pumping function and low iron levels. It aims to improve symptoms and quality of life.
Hear when a new Renal Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.